Document ID: chunk:federal_register_of_legislation:F2023L00016:reg:9:p8
Version: federal_register_of_legislation:F2023L00016
Segment Type: reg
Provision Reference: reg 9 (pt 8/8)
Character Range: 24650–25879

worsening of atrial fibrillation or atrial flutter.
Note: specified list of drugs is defined in the Schedule 1 - Dictionary.
(85)      taking a bisphosphonate: for a continuous period at least 30 days within the 60 days before the clinical worsening of atrial fibrillation or atrial flutter
(86)      inhaling ambient, chronically polluted air as specified for at least 1 year, within the 2 years before the clinical worsening of atrial fibrillation or atrial flutter;
Note: ambient, chronically polluted air as specified is defined in the Schedule 1 – Dictionary.
(87)      inhaling ambient, highly polluted air as specified for at least the 30 days before the clinical  worsening of atrial fibrillation or atrial flutter;
Note: ambient, highly polluted air as specified is defined in the Schedule 1 – Dictionary.
(88)      having a viral lower respiratory tract infection within the 30 days before the clinical worsening of atrial fibrillation or atrial flutter;
Note: Examples of causes of viral lower respiratory tract infections include severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza virus.
(89)      inability to obtain appropriate clinical management for atrial fibrillation and atrial flutter.